5-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrimidin-2-amine

Catalog No.: 
ACCEYS618
CAS No.: 
1621416-54-3
Molecular Formula: 
C15H19BN4O2
Molecular Weight: 
298.15
5-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrimidin-2-amine
IUPAC Name5-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyrimidin-2-amine
Molecular FormulaC15H19BN4O2
Molecular Weight298.15
SMILESCC1(C)C(C)(C)OB(C2=CN=C(C3=CN=C(N)N=C3)C=C2)O1
InChI KeyZDLJNQXQQYYLJT-UHFFFAOYSA-N
Synonym2-Pyrimidinamine, 5-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]-
CAS No.1621416-54-3

Synthetic Route by SureRoute

1. ACCEYS618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCEYS618 route product structure diagram
    ACCEYS6181621416-54-3
Inquiry

2. ACCEYS618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXIZU058 route compound structure diagram
    ACXIZU058444120-94-9In Stock
  2. Plus
  3. ACVORQ496 route compound structure diagram
    ACVORQ496402960-38-7In Stock
  4. Then
  5. ACCEYS618 route product structure diagram
    ACCEYS6181621416-54-3
Inquiry

3. ACCEYS618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRYEP305 route compound structure diagram
    ACRYEP305214360-62-0In Stock
  2. Plus
  3. ACWIRL690 route compound structure diagram
    ACWIRL690936250-22-5In Stock
  4. Then
  5. ACCEYS618 route product structure diagram
    ACCEYS6181621416-54-3
Inquiry

Comments (0)